Mevalonate pathway and thecal-interstitial function

甲羟戊酸途径和鞘间质功能

• 批准号: 7501132
• 负责人: Antoni J Duleba
• 金额: $ 31.68万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-22 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7501132
• 关键词: Address; Affect; Androgens; Antioxidants; Cholesterol; Clinical; Clinical Trials; Condition; Depth; Development; Functional disorder; Growth; Human; Hyperplasia; Light; Luteinizing Hormone; Mesenchyme; Monomeric GTP-Binding Proteins; Ovarian; Oxidative Stress; Pathway interactions; Phosphorylation; Play; Polycystic Ovary Syndrome; Production; Rattus; Research; Role; Signal Transduction Pathway; Simvastatin; Steroid biosynthesis; Testing; Testosterone; Tissues; Vascular Smooth Muscle; Woman; base; design; insight; interstitial; interstitial cell; isoprenylation; mevalonate; novel; novel therapeutics; research study; rho

DESCRIPTION (provided by applicant): Appropriate ovarian development and function require mechanisms regulating growth and steroidogenesis of theca-interstitial cells. Under pathological conditions such as polycystic ovary syndrome (PCOS), theca-interstitial compartment is hyperplastic and produces excessive amounts of androgens. This proposal is designed to test the novel hypothesis that the mevalonate pathway plays an important role in modulation of growth and function of the ovarian theca-interstitial cells. We postulate that mevalonate pathway affects theca-interstitial cells by: (i) altering isoprenylation of small GTPases such as Ras and Rho affecting thus signal transduction pathways regulating growth, (ii) modulating the availability of substrates for steroidogenesis, and (iii) altering the level of oxidative stress, which, in turn, affects growth and steroidogenesis. Ultimately, we propose that, inhibition of the mevalonate pathway by agents such as statins may correct major features of PCOS including excessive growth of theca-interstitial cells, excessive androgen production and oxidative stress. This hypothesis is based on evidence that in several tissues, such as vascular smooth muscle, products of the mevalonate pathway facilitate isoprenylation of small GTPases and thus activate signal transduction pathways promoting growth. In vascular smooth muscle and in several other tissues, inhibition of the mevalonate pathway by statins inhibits growth, exerts antioxidant effects and decreases cholesterol synthesis. Our preliminary studies have shown that moderate oxidative stress increases and statins inhibit proliferation and steroidogenesis of theca-interstitial cells while blocking ERK1/2 phosphorylation. We have also completed a pilot clinical trial and we found that simvastatin decreases testosterone and luteinizing hormone in women with PCOS. The specific aims of this proposal are to study in depth the role of the mevalonate pathway in theca-interstitial cells on: (i) growth, (ii) steroidogenesis and (iii) oxidative stress. These aims will be addressed by experiments on rat and human theca-interstitial cell cultures. The results of these studies will provide a new insight into the role of mevalonate pathway on the growth and function of ovarian mesenchyme. Ultimately, the proposed research may shed new light on the pathophysiology of PCOS and provide an impetus towards the development of new therapeutic approaches, such as clinical use of statins.

描述（由申请人提供）：适当的卵巢发育和功能需要调节卵泡膜间质细胞生长和类固醇生成的机制。在多囊卵巢综合征（PCOS）等病理条件下，卵泡膜间质室增生并产生过量的雄激素。该提议旨在验证新的假设，即甲羟戊酸途径在调节卵巢卵泡膜间质细胞的生长和功能中起重要作用。我们推测甲羟戊酸途径通过以下方式影响卵泡膜间质细胞：（i）改变小GTP酶（如Ras和Rho）的异戊二烯化，从而影响调节生长的信号转导途径，（ii）调节类固醇生成底物的可用性，以及（iii）改变氧化应激水平，进而影响生长和类固醇生成。最后，我们提出，抑制甲羟戊酸途径的药物，如他汀类药物可能会纠正PCOS的主要特征，包括过度生长的卵泡膜间质细胞，过量的雄激素产生和氧化应激。这一假说基于以下证据：在几种组织中，如血管平滑肌，甲羟戊酸途径的产物促进小GTP酶的异戊二烯化，从而激活促进生长的信号转导途径。在血管平滑肌和其他几种组织中，他汀类药物抑制甲羟戊酸途径可抑制生长，发挥抗氧化作用并减少胆固醇合成。我们的初步研究表明，适度的氧化应激增加，他汀类药物抑制膜间质细胞的增殖和类固醇合成，同时阻断ERK 1/2磷酸化。我们还完成了一项试点临床试验，我们发现辛伐他汀降低PCOS妇女的睾酮和黄体生成素。该提案的具体目的是深入研究膜间质细胞中甲羟戊酸途径对以下方面的作用：（i）生长，（ii）类固醇生成和（iii）氧化应激。这些目标将通过对大鼠和人类卵泡膜间质细胞培养物的实验来解决。这些研究结果将为了解甲羟戊酸途径在卵巢间质生长和功能中的作用提供新的视角。最终，拟议的研究可能会揭示PCOS的病理生理学，并为开发新的治疗方法提供动力，例如他汀类药物的临床应用。